Sponsor or institution

Clinical trials and research at PMV Pharmaceuticals, Inc

• 2Clinical trials
• 9Countries

All recruiting trials (2)

• Rezatapopt's effect on common drug levels in people with advanced solid tumors carrying the TP53 Y220C mutation.

  This test sees if rezatapopt changes how common drugs—metformin, rosuvastatin, repaglinide, and midazolam—are processed in people with advanced solid tumors that carry the TP53 Y220C mutation.

  Recruiting at 5 sites Phase 1 PMV Pharmaceuticals, Inc · Denver, Colorado and 4 other locations · NCT07372625

• Evaluating PC14586 for advanced solid tumors with a specific mutation

  This study is testing a new oral medication called PC14586 to see if it can help people with advanced solid tumors that have a specific mutation in the TP53 gene.

  Recruiting at 71 sites Phase 1/2 PMV Pharmaceuticals, Inc · Irvine, California and 75 other locations · NCT04585750

Quick answers

How many clinical trials run by PMV Pharmaceuticals, Inc are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 9 countries. The most sites are in United States (2 trials), Australia (1 trial), France (1 trial), Germany (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →